Literature DB >> 580077

Lymphocytotoxic antibodies in patients with inflammatory bowel disease and their spouses--evidence for a transmissible agent.

R G Strickland, W C Miller, N A Volpicelli, R F Gaeke, I D Wilson, J B Kirsner, R C Williams.   

Abstract

Serum lymphocytotoxic antibodies (LCA) were detected in twenty-seven out of fifty-three (51%) patients with inflammatory bowel disease (IBD) and in twenty-three out of their fifty-three (43%) unaffected spouses. The prevalence of LCA in both groups was significantly increased (P less than 0.001) compared to that in age- and sex-matched controls (11%) or in control spouses (6%). Concordant expression of LCA occurred in sixteen out of the fifty-three (30%) patient-spouse pairs compared to only one out of the fifty-three (2%) control-spouse pairs (P less than 0.001). In contrast to the LCA results, heterophile antibody titres were similarly distributed in all four study groups. It is suggested that LCA may represent markers of infectious agents in IBD and that their occurrence in unaffected close contacts of patients may indicate transmission of such agents to these subjects.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 580077      PMCID: PMC1541129     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Lymphocytotoxic and RNA antibodies in inflammatory bowel disease: a comparative study in patients and their families.?

Authors:  S J Korsmeyer; R C Williams; I D Wilson; R G Strickland
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  SEROLOGIC DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS. A COMPARATIVE STUDY OF FIVE TESTS.

Authors:  I DAVIDSOHN; C L LEE
Journal:  Am J Clin Pathol       Date:  1964-02       Impact factor: 2.493

3.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

4.  Serum lymphocytotoxic and lymphocytophilic antibody activity in inflammatory bowel disease.

Authors:  S Korsmeyer; R G Strickland; I D Wilson; R C Williams
Journal:  Gastroenterology       Date:  1974-10       Impact factor: 22.682

5.  Electron microscopic studies of viral agents in Crohn's disease.

Authors:  G L Gitnick; V J Rosen
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

6.  Serum lymphocytotoxins in inflammatory bowel disease. Studies of frequency and specificity for lymphocyte subpopulations.

Authors:  R G Strickland; E M Friedler; C A Henderson; I D Wilson; R D Williams
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

7.  Lymphocytotoxins in acute and chronic hepatitis. Characterization and relationship to changes in circulating T lymphocytes.

Authors:  R J Dehoratius; C Henderson; R G Strickland
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

8.  Cultivation of viral agents from Crohn's disease. A new sensitive system.

Authors:  G L Gitnick; M H Arthur; I Shibata
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

9.  Characterization of anti-lymphocyte antibodies in inflammatory bowel disease.

Authors:  C A Henderson; L Greenlee; R C Williams; R G Strickland
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

10.  Lymphocytotoxic antibody in inflammatory bowel disease. A family study.

Authors:  S J Korsmeyer; R C Williams; I D Wilson; R G Strickland
Journal:  N Engl J Med       Date:  1975-11-27       Impact factor: 91.245

View more
  6 in total

1.  Serum lymphocytotoxic activity in leprosy.

Authors:  F N Rasheed; M Locniskar; D J McCloskey; R S Hasan; T J Chiang; P Rose; R de Soldenhoff; H Festenstein; K P McAdam
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

2.  Immune complexes in ulcerative colitis.

Authors:  R P Learmonth; E Pihl; W R Johnson
Journal:  Dig Dis Sci       Date:  1984-04       Impact factor: 3.199

3.  Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis.

Authors:  T Hibi; S Aiso; T Yoshida; M Watanabe; H Asakura; S Tsuru; M Tsuchiya
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

4.  Circulating lipid A antibodies despite absence of systemic endotoxemia in patients with Crohn's disease.

Authors:  W Kruis; P Schussler; M Weinzierl; C Galanos; J Eisenburg
Journal:  Dig Dis Sci       Date:  1984-06       Impact factor: 3.199

5.  Seropositivity in Dutch Crohn's disease patients against primed nude mouse lymph nodes, and the difference with lymphocytotoxic antibodies.

Authors:  A S Pena; I Kuiper; H C Walvoort; H W Verspaget; I T Weterman; E J Ruitenberg; K M Das
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

6.  Lymphocytotoxic and microbial antibodies in Crohn's disease and matched controls.

Authors:  D Gump; E Caul; O Eade; H Greenberg; A Kapikian; B MacPherson; P Mitchell; K Parent; S Richmond; W Beeken
Journal:  Antonie Van Leeuwenhoek       Date:  1981-12       Impact factor: 2.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.